In contrast, in pancreatic neuroendocrine tumors, FTO promotes malignancy by enhancing APOE expression through FASN‐mediated lipid metabolism, suggesting an oncogenic role.54 The gene discussed is APOE; the disease is pancreatic neuroendocrine tumor.